Dentopain

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dentopain

Property Description
Active Ingredients Acetaminophen, Ibuprofen
Form Oral Solid (Tablet/Capsule)
Pharmacological Class Non-opioid Analgesic Combination
General Purpose Symptomatic relief of acute pain and inflammation
Origin Synthetic Compound

What Type of Medicine is Dentopain? (Identity and Classification)

Dentopain is defined as a fixed-dose combination product, which is a non-opioid analgesic containing two distinct active compounds in an oral solid form. Pharmacologically, it is classified as a combination of a Non-Steroidal Anti-Inflammatory Drug (NSAID) and a Para-aminophenol derivative. This composition is clinically recognized for its ability to provide multimodal analgesia and is frequently used as a first-line option for acute, short-term discomfort, such as muscle strain.

The Composition: A Rational Drug Combination

The formulation incorporates the active ingredients, Ibuprofen and Acetaminophen (Paracetamol), selected for their complementary mechanisms of action. Ibuprofen functions primarily as a peripheral analgesic and anti-inflammatory agent, while Acetaminophen acts predominantly as a central analgesic and antipyretic. The integration of two separate pain-modulating agents is a rational drug combination established to maximize efficacy while remaining a non-opioid analgesic. The combination is specifically formulated to capitalize on these complementary mechanisms in a fixed-dose ratio.

General Purpose and Synergistic Benefit

The general purpose of Dentopain is to deliver effective symptomatic treatment by concurrently reducing inflammation and elevating the pain threshold. The principal benefit lies in its synergistic and multimodal action, which leverages the strengths of both components to achieve a broader and more potent effect than either agent administered alone. This simultaneous targeting of pain signaling and inflammatory pathways makes the drug a potent option for the rapid and sustained management of discomfort.

Regulatory References

  1. Acetaminophen and Ibuprofen (Oral Route)

What side effects are possible with Dentopain?

Possible Side Effects and Safety Information

The official safety information for Dentopain is primarily structured around significant risks associated with its combination of active ingredients. These include warnings regarding serious and potentially fatal adverse reactions.


Serious and Clinically Significant Risks

Regulatory documentation includes a Boxed Warning concerning the potential for serious cardiovascular thrombotic events, such as heart attack and stroke, which may increase with prolonged use or higher doses. The product is also associated with the risk of serious gastrointestinal bleeding, ulceration, and perforation. Due to the acetaminophen component, there is a serious, potentially fatal risk of liver failure (hepatotoxicity).

Adverse Reactions by Frequency

Adverse reactions documented in regulatory sources are classified by frequency. Common side effects typically involve the gastrointestinal system (e.g., nausea, indigestion) and the nervous system (e.g., headache, dizziness). Rare events include severe allergic reactions (anaphylaxis) and severe skin reactions.

Safety Restrictions and Populations at Risk

The medicine is contraindicated following coronary artery bypass graft (CABG) surgery and in patients with active gastrointestinal bleeding or known hypersensitivity to the active components. Official warnings specify that individuals with pre-existing liver disease or those who consume three or more alcoholic drinks daily are at an increased risk for severe liver injury. The risk of serious heart and stroke events is noted as being higher if the product is used more or longer than directed.

Overdose and Emergency Response

Any suspected overdose of Dentopain requires immediate medical attention. Regulators explicitly mandate that individuals contact the Poison Control Center and do not wait for symptoms to appear, as severe outcomes can be delayed.

The initial documented manifestations of overdose may include Nausea, Vomiting, Diaphoresis (sweating), Abdominal Pain, Drowsiness, and Tinnitus. However, the combination carries the documented risk of severe, life-threatening systemic injury to multiple organs. These severe outcomes include Fatal Hepatic Necrosis and Liver Failure (from the Acetaminophen component) and Acute Renal Failure, Gastrointestinal Hemorrhage, and Cardiovascular Collapse (from the Ibuprofen component). Altered mental status progressing to Coma is also a documented risk.

For management, Hospital Monitoring for a minimum of 24 hours is required for suspected Acetaminophen toxicity. N-acetylcysteine (NAC) is available as a specific antidote for the Acetaminophen component. Patients with underlying hepatic impairment or chronic alcoholism are noted to have an increased risk of severe hepatic injury following an overdose.

Therapeutic Uses of Dentopain

What Dentopain treats: Main Uses and Benefits

Treating Acute Pain and Inflammation

This combination analgesic is generally used for the symptomatic relief of mild to moderate acute pain that arises alongside localized inflammation, being applicable within clinical settings that involve acute or disruptive symptom patterns. It is relevant for easing symptoms such as headache, toothache (odontalgia), backache, muscular aches, and menstrual cramps (dysmenorrhea). The medication may provide support that helps ease the overall symptom burden related to physical discomfort and inflammatory or irritative states.

“This combination is commonly used across conditions presenting with acute episodes and offers symptomatic relief that supports patients during episodes of heightened discomfort.”


Managing Systemic Symptoms and Post-Procedural Discomfort

Dentopain is applied across therapeutic domains involving generalized systemic distress, such as the body aches and fever that accompany the cold or flu. It is also relevant for easing symptoms associated with acute or disruptive episodes. Furthermore, it is commonly used in clinical settings for postoperative pain following minor procedures like dental extractions. It offers symptomatic relief and may assist with maintaining a sense of stability when symptoms interfere with daily functioning.

Quick Fact: Relief for Musculoskeletal Pain

Regulatory References

  1. NIH DailyMed official product labeling

Eligibility and Restrictions for Use

Eligibility and Contraindications for Dentopain

This section outlines the official population eligibility and exclusion criteria for Dentopain (Acetaminophen/Ibuprofen combination), based on governmental regulatory documents.

Who is Generally Eligible?

Dentopain is approved for use in Adults and Adolescents (typically aged 12 years and older) for short-term symptomatic relief. Its safety and efficacy are not established for Children younger than 12 years, for whom use is generally not recommended.

Who Must Not Use Dentopain (Contraindications)

Official regulations strictly prohibit the use of Dentopain in individuals with the following absolute contraindications:

  • Known Hypersensitivity to Ibuprofen, Acetaminophen, any Non-Steroidal Anti-Inflammatory Drug (NSAID), or the product's excipients.
  • Severe Organ Impairment: Patients with severe, uncontrolled heart failure (NYHA Class IV), renal failure (e.g., Creatinine Clearance <30 ml/min), or hepatic failure.
  • Gastrointestinal History: Active or a history of recurrent peptic ulceration or gastrointestinal bleeding/perforation.
  • Pregnancy: Use is absolutely contraindicated during the third trimester of pregnancy (after 30 weeks).
  • Surgical Status: In the peri-operative setting of Coronary Artery Bypass Graft (CABG) Surgery.

Conditional Use and Restrictions

Patients with mild to moderate renal or hepatic impairment, uncontrolled hypertension, pre-existing cardiovascular risk factors, or a history of NSAID-exacerbated asthma must use Dentopain only under medical supervision and with caution, adhering to specific restrictions found in the product labeling. Use during the first and second trimesters of pregnancy or while breastfeeding is generally not recommended unless considered essential.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interaction Classifications and Scope

The regulatory interaction profile for this combination is defined by the risks of additive toxicity, pharmacokinetic changes, and pharmacodynamic interference, as documented by official government sources.

Classification Official Regulatory Constraint
Contraindicated Combinations Co-administration is strictly prohibited with any other Acetaminophen-containing product or other NSAID-containing product (prescription or nonprescription) due to the severe, additive risk of liver and gastrointestinal toxicity. Use is also contraindicated for pain related to Coronary Artery Bypass Graft (CABG) surgery.
High-Risk Additive Effects Concomitant use with Anticoagulants (e.g., Warfarin) or Corticosteroid drugs officially increases the risk of bleeding or ulceration. The Ibuprofen component may also interfere with the antiplatelet effect of low-dose aspirin.
Exposure-Altering Effects Regulatory documents state that use may cause increased plasma concentrations of co-administered agents such as Lithium and Methotrexate by reducing their renal clearance.
Timing-Based Rules Administration must be separated by at least 8 hours before or 30 minutes after immediate-release aspirin to minimize interference with its antiplatelet effect.

Non-Medicinal Substance and Population Notes

Severe liver damage and gastrointestinal bleeding risks are explicitly increased for users who consume 3 or more alcoholic drinks every day. Regulatory cautions also apply to specific populations; use requires heightened consideration for patients with severe hepatic impairment due to the Acetaminophen component’s metabolic risks and for patients age 60 or older due to a stated higher risk of severe stomach bleeding.

Mechanism of Action

Dentopain operates through a multimodal pharmacodynamic mechanism, utilizing two complementary actions to modulate specific enzyme and signaling pathways at both the peripheral and central levels.

Mechanism 1: Peripheral Inhibition of Inflammatory Signaling

This component acts by reversibly blocking the Cyclooxygenase (COX) enzymes (COX-1 and COX-2) at sites of tissue injury. This molecular action directly suppresses the production of key prostaglandins (PGE2), which are chemical mediators responsible for sensitizing peripheral pain receptors (nociceptors) and promoting local inflammation. The resulting physiological effect is a diminished input of inflammatory signals to the central nervous system.

Mechanism 2: Central Pain Threshold and Thermoregulation Modulation

The second component primarily acts within the Central Nervous System (CNS), exerting effects via a distinct mechanistic pathway. This involves modulating central pain pathways—including the inhibition of CNS COX isoenzymes—which functionally leads to an elevation of the body’s pain threshold and a reduction in signal amplification within the spinal cord. This action is also critical for targeting the hypothalamic thermoregulatory center, adjusting the hypothalamic set-point towards normal physiological levels.

Synergistic Action for Broader Pathway Engagement

The combination's mechanism is characterized by synergistic action: one mechanism limits the creation of pain signals peripherally, while the other modulates the transmission and perception of those signals centrally. This coordinated engagement across distinct mechanistic domains results in a broader mechanistic coverage of the pain and inflammation signaling pathways.

Dosage and Administration Information

How to Use Dentopain: Administration Principles

The usage of Dentopain, a fixed-dose combination analgesic, follows established administration protocols. The primary route of administration for Dentopain is oral, delivered as a tablet or caplet, although the combination product also exists as an intravenous (IV) solution intended for use in supervised clinical settings.


Standard Dosing and Frequency

Dosing is structured around a non-continuous, as-needed (p.r.n.) schedule. For the common oral formulation, the typical initial dose is two tablets, providing 500 mg of Acetaminophen and 250 mg of Ibuprofen combined. This single dose is generally taken every eight hours, or as required for symptoms, adhering to a minimum interval between doses. A strict maximum daily dose limit exists, which must not be exceeded in any 24-hour period.


Contextual Constraints and Duration

The medication is utilized for the shortest necessary duration and is intended exclusively for short-term use. Dentopain is not to be co-administered with any other medicinal products that contain Acetaminophen or Ibuprofen/NSAIDs, as this may lead to exceeding the defined daily limits for the individual components. Furthermore, the product is not intended for use in children under 12 years of age. Administration with food may be considered, but tablets should not be crushed to achieve partial doses.

Recent Clinical Evidence

Dentopain: Recent Clinical Evidence

Published research into Dentopain has explored its characteristics and examined its use in specific patient populations. The studies examined endpoints related to the severity and duration of symptoms, and have explored the effect on the quality of life for patients within the study groups.


Initial Clinical Trials

Early Phase 2 and Phase 3 clinical trials focused primarily on patients with moderate to severe presentations of the condition. These initial studies explored measured changes in pain and inflammation, evaluating the timing of any observed findings and the duration of effects on clinical markers.

  • The examined population in studies included patients with moderate to severe illness who met specific inclusion criteria.
  • Studies have evaluated the drug at various exposure levels.

Safety and Patient Groups

A key area of research has included studies of the drug's safety measures and its use in various patient groups.

Pregnancy and Breastfeeding

Studies have excluded or are limited in data on patients who may be pregnant or breastfeeding, due to ethical constraints and population size. It is not yet clear whether the drug has an effect on the fetus or newborn.

Drug Interactions

Research has examined potential interactions between this treatment and other immunosuppressants. Data from this research is being used to evaluate the characteristics of combined use.

Long-Term Effects

Long-term observational studies have evaluated endpoints related to disease flare-ups over a period of 5 years. Research has also examined the combination of X and Y to describe its profile.

Key Studies & References

  1. A randomized, double-blind pilot study of analgesic and anti-inflammatory effects of naproxen sodium and acetaminophen following dental implant placement surgery
  2. The Safety and Efficacy of Pre- and Post-Medication for Postoperative Endodontic Pain: A Systematic Review and Network Meta-analysis
  3. Recommendations for Management of Acute Dental Pain (IHS Clinical Guidelines)
  4. New Guideline Details Acute Pain Management Strategies for Adolescent, Adult Dental Patients (referencing ADA guidelines)

Frequently Asked Questions (FAQ)

Common questions about Dentopain (FAQ)

Q: Can Dentopain be taken for general headaches or body aches?

Official product information indicates that the medicine is approved for the temporary relief of minor aches and pains. This includes pain stemming from common conditions such as headaches, backaches, and muscular aches, among other conditions.

Q: How quickly does Dentopain start to work for pain relief?

Studies evaluating the medicine's effect indicate that the median time to experience meaningful pain relief is generally achieved in less than one hour after the dose is administered. However, the timing of effects can vary among individuals.

Q: How long does one dose of Dentopain typically last?

Clinical data suggests that pain relief from a single dose typically lasts for up to 8 to 11 hours. This duration is consistent with the standard recommended minimum interval between doses.

Q: Is Dentopain safe for older adults or seniors?

Regulatory information states that older adults are more prone to certain age-related health issues, such as heart, liver, or kidney problems. Therefore, regulatory information advises that use in this population may require heightened caution and professional assessment due to these increased potential risks.

Q: Do studies show that Dentopain is effective for long-term chronic pain?

Official documentation restricts the use of this medicine to short-term management for acute symptoms. Long-term use of the active ingredients carries increased safety risks, and regulatory warnings are associated with prolonged administration.

Q: Does Dentopain affect alertness or the ability to drive?

The medicine has been associated with common side effects such as dizziness and drowsiness. Official warnings caution patients against operating machinery or driving until they understand the medicine's potential impact on their ability to maintain alertness.

Q: Are there different strengths of Dentopain available?

The Acetaminophen/Ibuprofen fixed-dose combination is available in multiple dosage forms and strengths. These variations include different tablet ratios, which may be designated for either prescription or over-the-counter use.

Q: What is the maximum number of days or weeks Dentopain is typically prescribed for?

Regulatory bodies generally restrict the use of this medicine to short-term management. For instance, the intravenous form is explicitly indicated for five days or less. Regulatory guidance advises that oral use for symptomatic relief typically be limited to 10 days or less.

Q: Is Dentopain intended for dental pain specifically, or other kinds of pain?

Official information confirms the medicine is approved for a variety of minor aches and pains. This includes specific pain types such as toothache, alongside other common pains like headache and backache.

Q: Do regulatory bodies advise specific monitoring while taking Dentopain?

Official documentation indicates that professional monitoring is often advised at regular intervals. This monitoring helps observe for potential effects, particularly those related to the heart, liver, and kidneys.

Q: Is it common to feel tired or drowsy while on Dentopain?

Drowsiness is listed in the official product information as a potential common side effect of the medicine. It is noted that individual experiences with side effects can vary.

Q: Is there a risk of physical dependence with Dentopain?

This medicine is classified as a non-opioid analgesic. Official sources indicate that the acetaminophen component of the combination product is generally not associated with becoming habit-forming even when taken over time.

Q: What are the major differences between Dentopain and over-the-counter pain relievers?

Dentopain is defined as a fixed-dose combination product, meaning it contains two distinct pain-relieving agents, offering a multimodal effect. Also, specific higher strengths of this combination product are available only by prescription, unlike many single-agent, over-the-counter pain relievers.

Q: What happens if I miss a scheduled dose of Dentopain?

Official guidance exists for managing a missed dose if the medicine is taken regularly. Typically, if the next scheduled dose is close, the missed dose is skipped to prevent taking too much medicine. Specific instructions are detailed on the product label.

Q: Can taking Dentopain cause difficulty sleeping?

Insomnia, or difficulty sleeping, has been reported as a common adverse event associated with the use of the acetaminophen component. This is noted in official documentation under the list of potential side effects.

Q: Why is Dentopain only available by prescription?

Regulatory classification is dependent on the specific dosage strength of the combination product. Higher strengths are often prescription-only due to the need for medical supervision concerning the known risks of serious side effects, such as gastrointestinal bleeding and severe liver injury.

Q: Is Dentopain used for any non-pain conditions?

One of the active compounds in the medicine, Acetaminophen, is known to be used to reduce fever. Therefore, the combination product includes the capacity for both pain relief and fever reduction.

Q: Why do some people experience dry mouth when using Dentopain?

Dry mouth has been reported as an adverse event associated with one of the active ingredients in the medicine. As with any medication, the frequency and severity of side effects can vary among individuals.

Q: What should be done if an allergic reaction is suspected after taking Dentopain?

Official patient labeling advises that emergency medical help should be sought immediately if signs of a severe allergic reaction are suspected. These signs can include hives, difficulty breathing, or swelling of the face, lips, tongue, or throat.

Q: Does Dentopain have a high potential for misuse?

The medicine is classified as a non-opioid analgesic, and the acetaminophen component is stated as not being habit-forming. The primary safety concern regarding misuse involves the risk of unintentional overdose (taking too much), which can lead to severe and potentially fatal liver damage.

How should Dentopain be stored and disposed of?

How to Store and Dispose of Dentopain?

The official storage and disposal requirements for Dentopain oral tablets are defined by regulatory labeling to ensure product stability and safety. The product must be maintained at Controlled Room Temperature (typically 20 C to 25 C). It is mandatory to keep the medicine out of the sight and reach of children due to ingestion risks.

Mandatory Storage Rules:

  • Store in the original, tightly closed container.
  • Must be protected from moisture and light.
  • Do not store in the refrigerator or freezer, and keep away from heat.
  • Do not use the medicine after the expiration date.

Official Disposal Instructions

To dispose of expired or unused medicine, regulatory guidance advises using a drug take-back program or an authorized collection point. Under no circumstances should Dentopain be flushed down the toilet or poured into the sink, as this violates environmental protection requirements for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dentopain found in:

A-Z Index: